The virtual masterclass will provide an overview on treatments and standard methods in evaluating the physiology and biology of asthma and chronic obstructive pulmonary disease (COPD). Special emphasis will be given to the pharmacological management and the monitoring of airway diseases using biomarkers, physiology and imaging. It will also discuss the latest guidelines available in asthma and COPD and offer the opportunity for participants to interact in case-based sessions and workshops.
This course has been accredited with 11 CME credits by the European Board for Accreditation in Pneumology (EBAP). The number of credits that you will receive will correspond to the time you spend viewing the sessions live. Please note that you will not accrue credits for watching video recordings made available after the course has taken place.
Course format
- Lectures
- Interactive workshops
- Case-based sessions
Please note that all timings are in Central European Time (CET). Recordings of each session will be made available to registered participants after the event.
Topics
- Biological phenotypes and endotypes and their clinical implication
- Biological therapy in airway diseases
- Imaging asthma and COPD
- Digital innovation
- COVID-19 and airway diseases
Learning outcomes
Following this course, participants will be able to:
- Have greater knowledge of pharmacological and non-pharmacological treatment
- Understand the investigation and management of asthma and COPD
- Work in teams in the follow-up of the disease
- Improve their communication skills
Target audience
- Clinicians
- Trainees
- Scientists
- Pulmonologists
- Research fellows
- Allied respiratory professionals
| Category | Fees |
| ERS member | €120 |
| Non-members | €180 |
Cancellation policy
Registration fees for this online activity are non-refundable.
Registering for someone else? Contact registration@ersnet.org